跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CONDROITINA SULFATO ROVI 400 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CONDROITINA SULFATO ROVI 400 MG CAPSULAS DURAS
Approved
STANDARD
CONDROITINA SULFATO ROVI 400 MG CAPSULAS DURAS
Laboratorios Farmaceuticos Rovi S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 10, 2021
Approval ID
ca6036ab2f4c2d02
Company
Laboratorios Farmaceuticos Rovi S.A.
Type
Standard
Approval Details
Approval Id
ca6036ab2f4c2d02
Drug Cima Aemps Name
CONDROITINA SULFATO ROVI 400 MG CAPSULAS DURAS
Register Number
83052
Holder Company Name
Laboratorios Farmaceuticos Rovi S.A.
Marketing Company Name
Laboratorios Farmaceuticos Rovi S.A.
Holder Company Detail Path
/organization/laboratorios-farmaceuticos-rovi-sa
Marketing Company Detail Path
/organization/laboratorios-farmaceuticos-rovi-sa
Authorization Date
2021-08-10
Dosage Form
CÁPSULA DURA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Farmaceuticos Rovi S.A.
Company Detail Path
/organization/laboratorios-farmaceuticos-rovi-sa
Company Information
Pharmaceutical Company Name
LABORATORIOS FARMACEUTICOS ROVI SA
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE JULIAN CAMARILLO 35
Website
https://www.rovi.es/en/
Active Ingredients
CONDROITINA SULFATO SODIO
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 10, 2021
Approval ID
ca6036ab2f4c2d02
Type
Standard
Back to CIMA-AEMPS Approvals